Related Experiment Videos
Candidal meningitis in HIV-infected patients: treatment with fluconazole
F Rodríguez-Arrondo1, K Aguirrebengoa, A De Arce
1Infectious Disease Unit of Hospital Aránzazu, San Sebastián, Spain.
Scandinavian Journal of Infectious Diseases
|November 17, 1998
Abstract:
Although mucocutaneous candidiasis is a common occurrence in HIV-infected patients, candidal meningitis is uncommon. We report 3 cases of candidal meningitis in HIV-positive patients, all intravenous drug abusers, and we discuss the clinical course and outcome, the treatment with fluconazole and possible prophylaxis.
Insights
Candidal meningitis is rare in HIV patients, even with common mucocutaneous candidiasis. This study details three cases in intravenous drug users, discussing treatment and prophylaxis.
Area of Science:
- Infectious Diseases
- Mycology
- HIV/AIDS Research
Background:
- Mucocutaneous candidiasis is prevalent in Human Immunodeficiency Virus (HIV)-infected individuals.
- Candidal meningitis, a serious fungal infection of the brain's lining, is infrequently observed in this population.
Observation:
- Three cases of candidal meningitis were identified in HIV-positive patients.
- All affected individuals were intravenous drug abusers (IDUs).
Findings:
- The study examines the clinical presentation, progression, and outcomes of these rare cases.
- Treatment strategies, including the use of fluconazole, were evaluated.
- The potential for prophylactic measures against candidal meningitis in high-risk HIV patients was considered.
Implications:
- Highlights the importance of considering invasive fungal infections like candidal meningitis in specific HIV subgroups.
- Informs clinical management and treatment protocols for HIV-positive individuals, particularly IDUs.
- Suggests a need for further research into preventative strategies for fungal meningitis in immunocompromised populations.